Janssen (BetaLogics) Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Janssen (BetaLogics) General Information

Description

Developer of transformational stem cell therapy to treat diabetes. The company is developing stem cell-derived therapy for diabetes treatment and to eliminate a need for exogenous insulin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
ViaCyte
Primary Office
  • Horsham, PA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen (BetaLogics) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen (BetaLogics)‘s full profile, request access.

Request a free trial

Janssen (BetaLogics) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Janssen (BetaLogics)‘s full profile, request access.

Request a free trial